4D Molecular Therapeutics Inc (FDMT)
R&D to Revenue
229.67%
Fiscal year · Period ending:
FDMT R&D to Revenue
Latest reported229.67%period ending
Latest reported229.67%period ending
FDMT FY R&D/Revenue (234.42% → 229.67%)
Latest values, visible window
High-resolution chart · PNG
FDMT r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 229.6659% | |
| 381,889.1892% | |
| 468.5422% | |
| 2,564.813% | |
| 340.1708% | |
| 389.6415% | |
| 627.7555% | |
| 129.9505% | |
| 234.4214% |